Hot Toddies Do Not Treat Influenza and Should Not Be Recommended
A hot toddy—or any alcoholic beverage—has no role in the treatment of influenza and should not be used for symptomatic relief. While hot non-alcoholic drinks may provide temporary comfort for upper respiratory symptoms, alcohol itself offers no therapeutic benefit and may worsen dehydration and interfere with immune function.
What the Evidence Actually Shows About Hot Drinks
Hot Non-Alcoholic Beverages May Provide Symptomatic Relief
- A hot fruit drink (without alcohol) provided immediate and sustained relief from runny nose, cough, sneezing, sore throat, chilliness, and tiredness in patients with common cold/flu symptoms 1
- The same drink at room temperature only relieved runny nose, cough, and sneezing—suggesting the heat itself contributes to symptom relief 1
- The mechanism is likely through increased salivation and airway secretions, not any antiviral effect 1
The Alcohol Component Has No Evidence Base
- No clinical guidelines or research studies support the use of alcohol-containing beverages for influenza treatment 2, 3, 4
- Alcohol can cause dehydration, which is counterproductive when adequate hydration is a cornerstone of influenza management 2
Evidence-Based Symptomatic Treatment for Influenza
First-Line Symptomatic Management
- Paracetamol (acetaminophen) is the first-line antipyretic and analgesic for fever, myalgias, and headache based on its favorable safety profile 2
- Ibuprofen may be used with caution as an alternative 2
- Antipyretics should be used to alleviate distressing symptoms, not solely to reduce temperature 2
Supportive Care Measures
- Rest and adequate hydration (drinking plenty of fluids, but no more than 2 liters per day) 2
- Avoid smoking 2
- Consider short-term use of topical decongestants, throat lozenges, or saline nose drops 2
- For distressing cough, consider codeine linctus, codeine phosphate tablets, or morphine sulfate oral solution 2
When Antiviral Therapy Is Indicated
Timing Is Critical
- Oseltamivir 75 mg orally twice daily for 5 days should be initiated within 48 hours of symptom onset if the patient has fever >38°C and symptom duration ≤2 days 2, 5
- The benefit is greatest when started within 24 hours of symptom onset 5
- Antiviral therapy decreases illness duration by approximately 24 hours and may reduce risk of serious complications 5
High-Risk Patients May Benefit Beyond 48 Hours
- Patients with high-risk features (age <2 years or ≥65 years, pregnancy, immunocompromise, chronic organ disease, severe illness, or complications) should receive oseltamivir even after 48 hours because mortality benefit persists up to 96 hours 2
- Reduce oseltamivir to 75 mg once daily when creatinine clearance is <30 mL/min 2
Red Flags Requiring Immediate Medical Evaluation
When to Seek Urgent Care
- Shortness of breath at rest or with minimal activity 2
- Painful or difficult breathing 2
- Coughing up bloody sputum (hemoptysis) 2
- Drowsiness, disorientation, or confusion 2
- Fever persisting for 4-5 days without improvement 2
- Initial improvement followed by recurrence of high fever (suggesting bacterial superinfection) 2, 6
Common Pitfalls to Avoid
- Do not recommend alcohol-containing beverages as treatment—they provide no benefit and may cause harm through dehydration
- Do not prescribe antibiotics for previously healthy adults with acute bronchitis secondary to influenza when pneumonia is absent 2, 3
- Do not delay antiviral therapy in high-risk patients waiting for laboratory confirmation 2
- Do not use aspirin in children under 16 years due to risk of Reye's syndrome 2